256 related articles for article (PubMed ID: 33589539)
21. Impact of ST-Segment-Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non-ST-Segment-Elevation Myocardial Infarction.
Montoy JCC; Shen YC; Brindis RG; Krumholz HM; Hsia RY
J Am Heart Assoc; 2021 Feb; 10(3):e016932. PubMed ID: 33470136
[TBL] [Abstract][Full Text] [Related]
22. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
24. Relationship Between Myocardial Function, Body Mass Index, and Outcome After ST-Segment-Elevation Myocardial Infarction.
Joyce E; Hoogslag GE; Kamperidis V; Debonnaire P; Katsanos S; Mertens B; Marsan NA; Bax JJ; Delgado V
Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28701527
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
Redfors B; Dworeck C; Haraldsson I; Angerås O; Odenstedt J; Ioanes D; Petursson P; Völz S; Albertsson P; Råmunddal T; Persson J; Koul S; Erlinge D; Omerovic E
Eur Heart J; 2019 Apr; 40(15):1202-1210. PubMed ID: 30851037
[TBL] [Abstract][Full Text] [Related]
26. One-Year Outcomes After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Varying Quantities of Coronary Artery Calcium (from a 13-Year Registry).
Vaduganathan M; Kornowski R; Qamar A; Greenberg G; Bental T; Rechavia E; Lev EI; Vaknin-Assa H; Assali AR
Am J Cardiol; 2016 Oct; 118(8):1111-1116. PubMed ID: 27561193
[TBL] [Abstract][Full Text] [Related]
27. Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock.
Lee JM; Rhee TM; Hahn JY; Kim HK; Park J; Hwang D; Choi KH; Kim J; Park TK; Yang JH; Song YB; Choi JH; Choi SH; Koo BK; Kim YJ; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim JH; Kim HS; Jeong MH;
J Am Coll Cardiol; 2018 Feb; 71(8):844-856. PubMed ID: 29471935
[TBL] [Abstract][Full Text] [Related]
28. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale.
Fröbert O; Lagerqvist B; Gudnason T; Thuesen L; Svensson R; Olivecrona GK; James SK
Am Heart J; 2010 Dec; 160(6):1042-8. PubMed ID: 21146656
[TBL] [Abstract][Full Text] [Related]
29. Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction.
Wienbergen H; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Gohlke H; Senges J;
Clin Res Cardiol; 2008 Feb; 97(2):83-8. PubMed ID: 17938850
[TBL] [Abstract][Full Text] [Related]
30. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction - A report from the SWEDEHEART registry.
Redfors B; Vedad R; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Ali A; Dworeck C; Odenstedt J; Ioaness D; Libungan B; Shao Y; Albertsson P; Stone GW; Omerovic E
Int J Cardiol; 2015 Apr; 185():282-9. PubMed ID: 25818540
[TBL] [Abstract][Full Text] [Related]
31. Untangling the obesity paradox in patients with acute myocardial infarction after primary percutaneous coronary intervention (detail analysis by age).
Fukuoka S; Kurita T; Dohi K; Masuda J; Seko T; Tanigawa T; Saito Y; Kakimoto H; Makino K; Ito M
Int J Cardiol; 2019 Aug; 289():12-18. PubMed ID: 30665801
[TBL] [Abstract][Full Text] [Related]
32. Transradial versus transfemoral approach in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction: insight from the CREDO-Kyoto AMI registry.
Yamashita Y; Shiomi H; Morimoto T; Yaku H; Kaji S; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Abe M; Akao M; Nagao K; Shizuta S; Ono K; Kimura T;
Heart Vessels; 2017 Dec; 32(12):1448-1457. PubMed ID: 28698995
[TBL] [Abstract][Full Text] [Related]
33. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
[TBL] [Abstract][Full Text] [Related]
34. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
Sarno G; Lagerqvist B; Nilsson J; Frobert O; Hambraeus K; Varenhorst C; Jensen UJ; Tödt T; Götberg M; James SK
J Am Coll Cardiol; 2014 Jul; 64(1):16-24. PubMed ID: 24998123
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry.
Braga CG; Cid-Alvarez AB; Diéguez AR; Alvarez BA; Otero DL; Sánchez RO; Pena XS; Salvado VG; Trillo-Nouche R; González-Juanatey JR
Int J Cardiol; 2017 Sep; 243():21-26. PubMed ID: 28532984
[TBL] [Abstract][Full Text] [Related]
36. Impact of body mass index on long-term outcomes in Japanese patients following percutaneous coronary intervention: The Juntendo PCI Registry.
Endo H; Dohi T; Shitara J; Wada H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
J Cardiol; 2018 Sep; 72(3):208-214. PubMed ID: 29550145
[TBL] [Abstract][Full Text] [Related]
37. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.
Kang WY; Jeong MH; Ahn YK; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
J Cardiol; 2010 Jan; 55(1):84-91. PubMed ID: 20122553
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
Taniguchi T; Shiomi H; Morimoto T; Watanabe H; Ono K; Shizuta S; Kato T; Saito N; Kaji S; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Horie M; Kimura T
Am J Cardiol; 2017 Jun; 119(11):1729-1739. PubMed ID: 28407886
[TBL] [Abstract][Full Text] [Related]
39. Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention.
Ndrepepa G; Keta D; Byrne RA; Schulz S; Mehilli J; Seyfarth M; Schömig A; Kastrati A
Heart Vessels; 2010 Jan; 25(1):27-34. PubMed ID: 20091395
[TBL] [Abstract][Full Text] [Related]
40. Bivalirudin versus heparin with primary percutaneous coronary intervention.
Venetsanos D; Lawesson SS; James S; Koul S; Erlinge D; Swahn E; Alfredsson J
Am Heart J; 2018 Jul; 201():9-16. PubMed ID: 29910059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
